24 results
treatment hivaids idsa opportunistic prevention diagnosis hematology syndrome activetb latenttb tb tuberculosis anemia antiil6 aplastic apml aspergillosis aviumcomplex bartonella bartonellosis
IDSA Aspergillosis Treatment • Invasive pulmonary aspergillosis (IPA) • CNS aspergillosis • Cardiac Aspergillus infection •
Treatment • Invasive pulmonary ... • Aspergillus infections ... of eye Infectious ... Aspergillosis #Treatment #management ... #pharmacology #
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Diagnosis and Management ... = funny-shaped cells ... risk-stratification • Risks: infection ... acute leukemia Management ... treatment #hematology #oncology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS Treating Isospora belli Infection General Management Considerations: • Fluid
Infection in HIV-AIDS ... Infection General ... Management Considerations ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... Treating Acute Infection ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... • Pulmonary fibrotic ... • HIV: 2/3 pulmonary ... Langerhans giant cells ... TB #Diagnosis #Management
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
macrophages and T cells ... • Pulmonary fibrotic ... • HIV: 2/3 pulmonary ... Langerhans giant cells ... TB #Diagnosis #Management
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Release from blast cells ... Imaging: CXR- pulmonary ... Differential Diagnosis: Infection ... APML #diagnosis #management ... #hematology #oncology
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
Neutropenia - recurrent infections ... Idiopathic • Infections ... number of CD34+ cells ... Aplastic #Anemia #oncology ... hematology #diagnosis #management
Chronic Lymphocytic Leukemia (CLL) - Summary Overview: • Most common leukemia in adults • Disorder of
lymphocytes, smudge cells ... Complications: 1) Infection ... Lymphocytic #Leukemia #oncology ... hemeonc #diagnosis #management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19 IL-6 activates T cells and macrophages, among other cell types (see
-6 activates T cells ... respiratory tract infection ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
No results found for "Lellis management pediatrics pulmonary infections oncology pharmacology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Lellis #management #pediatrics #pulmonary #infections #oncology #pharmacology